efficacy

Sofen HL, Gebauer K, Spelman L, Yamauchi PS, Yao SL, Nishandar T, Kopeloff I, Crane M, Gogineni R, Kothekar M, Bagel J. Efficacy and Safety[...]

By sjmartinez • December 26, 2024

Burshtein J, Armstrong A, Chow M, DeBusk L, Glick B, Gottlieb AB, Gold LS, Korman NJ, Lio P, Merola J, Rosmarin D, Rosenberg A, Van[...]

By sjmartinez • December 22, 2024

Clement ME, Hanscom B, Haines D, Bazan JA, Chotirosniramit N, Kofron R, Mannheimer S, Mayer KH, Torres Silva MS, Soto-Torres L, Rinehart AR, Rooney JF,[...]

By sjmartinez • November 24, 2024

Bahlis NJ, Samaras C, Reece D, Sebag M, Matous J, Berdeja JG, Shustik J, Schiller GJ, Ganguly S, Song K, Seet CS, Acosta-Rivera M, Bar[...]

By sjmartinez • September 6, 2024

Gebauer K, Spelman L, Yamauchi PS, Bagel J, Nishandar T, Crane M, Kopeloff I, Kothekar M, Yao SL, Sofen HL. Efficacy and safety of tildrakizumab[...]

By sjmartinez • June 22, 2024

Fishbane S, Clegg DJ, Lerma EV, Rastogi A, Budden J, Morin I, Wen W, Menzaghi F, Topf J. Difelikefalin in Black/African American Hemodialysis Patients with[...]

By sjmartinez • June 4, 2024

Hoeper MM, Ewert R, Jansa P, Sirenko Y, Skride A, Balagtas C, Hackley S, Vogt S, Abreu P, Haughie S, Hassan T, Oudiz RJ. Randomized,[...]

By sjmartinez • May 16, 2024

Masson R, Park SE, Shih T, Hogeling M, Shi VY, Hsiao JL. Spironolactone in hidradenitis suppurativa: a single-center. Int J Womens Dermatol. 2024 Mar 19;10(1):e135.[...]

By sjmartinez • March 20, 2024

Corren J, Szefler SJ, Sher E, Korenblat P, Soong W, Hanania NA, Berman G, Brusselle G, Zitnik R, Natalie CR, Sun L, Siu K, Wu[...]

By sjmartinez • February 16, 2024

Kingston P, Blauvelt A, Strober B, Armstrong AW. Deucravacitinib: a novel TYK2 inhibitor for the treatment of moderate-to-severe psoriasis. J Psoriasis Psoriatic Arthritis. 2023 Oct;8(4):156-165.[...]

By sjmartinez • January 8, 2024